Medical Marijuana Research Act

Bill: 117-hr-5657
Sponsor: Rep. Blumenauer, Earl [D-OR-3]
Introduced: 2021-10-21 in the House
Policy area: Health
Subjects: Administrative law and regulatory procedures
Alternative treatments
Crime and Law Enforcement
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug therapy
Drug trafficking and controlled substances
Food and Drug Administration (FDA)
Health personnel
Licensing and registrations
Medical research
Research administration and funding

Summary:
action_date: 2021-10-21
text: 

Medical Marijuana Research Act

 
This bill establishes a new, separate registration process to facilitate medical marijuana research.
 
Specifically, it directs the Drug Enforcement Administration to register (1) practitioners to conduct medical marijuana research, and (2) manufacturers and distributors to supply marijuana for such research.
 
Additionally, the Department of Health and Human Services must continue to produce marijuana through the National Institute on Drug Abuse Drug Supply Program and implement a specialized process for supplying marijuana products available through state-authorized marijuana programs to researchers until manufacturers and distributors can provide a sufficient supply of marijuana for medical research.

action_date: 2022-04-04
text: 

Medical Marijuana Research Act

 
This bill establishes a new, separate registration process to facilitate medical marijuana research.
 
Specifically, it directs the Drug Enforcement Administration to register (1) practitioners to conduct medical marijuana research, and (2) manufacturers and distributors to supply marijuana for such research.
 
Additionally, the Department of Health and Human Services must continue to produce marijuana through the National Institute on Drug Abuse Drug Supply Program and implement a specialized process for supplying marijuana products available through state-authorized marijuana programs to researchers until manufacturers and distributors can provide a sufficient supply of marijuana for medical research.


Legislative actions:
action_date: 2022-04-05
text: Received in the Senate.
action_date: 2022-04-04
text: Motion to reconsider laid on the table Agreed to without objection.
action_date: 2022-04-04
text: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 343 - 75 (Roll no. 108). (text: CR H4136-4138)
action_date: 2022-04-04
text: Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 343 - 75 (Roll no. 108).(text: CR H4136-4138)
action_date: 2022-04-04
text: Considered as unfinished business. (consideration: CR H4144-4145)
action_date: 2022-04-04
text: At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
action_date: 2022-04-04
text: DEBATE - The House proceeded with forty minutes of debate on H.R. 5657.
action_date: 2022-04-04
text: Considered under suspension of the rules. (consideration: CR H4136-4140)
action_date: 2022-04-04
text: Mr. Pallone moved to suspend the rules and pass the bill, as amended.
action_date: 2021-10-22
text: Referred to the Subcommittee on Health.
action_date: 2021-10-21
text: Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2021-10-21
text: Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2021-10-21
text: Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2021-10-21
text: Sponsor introductory remarks on measure. (CR E1126)
action_date: 2021-10-21
text: Introduced in House
action_date: 2021-10-21
text: Introduced in House